U.S. markets open in 3 hours 40 minutes

Shockwave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
190.18-6.13 (-3.12%)
At close: 04:00PM EDT
190.16 -0.02 (-0.01%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close196.31
Bid0.00 x 800
Ask0.00 x 900
Day's Range188.27 - 195.00
52 Week Range172.50 - 320.54
Avg. Volume531,865
Market Cap7.209B
Beta (5Y Monthly)0.98
PE Ratio (TTM)31.96
EPS (TTM)5.95
Earnings DateNov 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est278.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
47% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SWAV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ShockWave Medical, Inc.
    SWAV: Lowering target price to $157.00SHOCKWAVE MEDICAL INC has an Investment Rating of SELL; a target price of $157.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Motley Fool

    3 Healthcare Stocks to Keep an Eye On

    Shockwave Medical (NASDAQ: SWAV), Bio-Techne (NASDAQ: TECH), and Ginkgo Bioworks (NYSE: DNA) may not be well-known to a lot of investors, but all three healthcare stocks could double over the next few years thanks to their strong growth potential. The reason these three may not be familiar names is that they don't sell their products to the general public, but instead to healthcare professionals and pharmaceutical companies. Bio-Techne and Ginkgo Bioworks are good examples of pick-and-shovel companies in the gene-editing industry, while Shockwave Medical sells its products to healthcare systems for their use on patients.


    Insider Sell: Isaac Zacharias Sells 4,000 Shares of ShockWave Medical Inc

    On September 26, 2023, President and Chief Commercial Officer Isaac Zacharias sold 4,000 shares of ShockWave Medical Inc (NASDAQ:SWAV).

  • Insider Monkey

    Multiple Tailwinds Pushed Shockwave Medical (SWAV) in Q2

    TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the second quarter, the strategy underperformed the Russell 2000 Growth Index and returned 2.50% (net), and the index return was 7.05%. Consumer Staples, Health Care, Industrials, and Information […]